Pharmaceutical Companies Rush To Patent Medical Marijuana - GRRRRRRR

Discussion in 'Medical Marijuana Patients' started by Beaches Compassion, Jun 14, 2013.

    Beaches Compassion

    Beaches Compassion Active Member

    :twisted: :twisted:

    Written by Johnny Green
    It seems like one of the greatest fears of the medical marijuana community is slowly being realized, as corporations quickly adopt cannabinoids into their vast profile of patented medicines. Leading the charge is GW Pharmaceuticals (1), a UK- based pharmaceutical company who manufacturers Sativex, an outrageously overpriced oral spray that relies on THC and CBD for its medical effects.

    Although Sativex is not currently available to patients in the U.S., it can be prescribed in Canada, the UK and other European countries, at a price of £175 per bottle. As crazy as it sounds, the only difference between a £175 bottle of Sativex and a $20 bottle of marijuana extract from your local dispensary are the patents that GW Pharma has been all-too-quick to file.
    Just last month, GW Pharma’s newest patent application (2) was published with the title “Phytocannabinoids in the treatment of cancer.” That’s right, the makers of Sativex are trying to patent the compounds of marijuana for treating all forms of cancer. But is that even allowed?
    Probably not, since medical marijuana’s cancer-fighting effects have been well known since the 70s, not to mention prominent spokespeople of the movement, such as Rick Simpson, who have provided personal testimonies of marijuana’s ability to cure cancer. As a result, it is unlikely that a patent would be granted on medical marijuana itself or common extracts like hemp oil.
    Even still, pharmaceutical companies are well aware of the loopholes in patent laws that can easily be exploited by slightly altering a chemical or formula, which is what seems to be the case with GW Pharma. In their most recent patent, all GW Pharma had to do to claim exclusive rights to the cancer-fighting effects of cannabis was to call it a “botanical drug substance”, which they define as a mixture of cannabinoids and non-cannabinoid materials. As a result, GW may just be holding the golden ticket to a cutting-edge cure for cancer, something that has eluded medical research for decades.
    It’s interesting to note that GW is not the first to exploit the medical properties of marijuana by form of a patent. In fact, it is almost common knowledge among the medical marijuana community that the U.S. government has been actively involved in obtaining patent rights on cannabinoids. Patent #6630507 (3) was granted to the Department of Health and Human Services in 2003 for “Cannabinoids as antioxidants and neuroprotectants,” which clearly outlines their usefulness as a treatment for stroke, Alzheimer’s disease, Parkinson’s disease and dementia.
    Unfortunately, it’s not just GW Pharma and the feds than seem interested in monopolizing the medical marijuana market. Cannabinoid patents have been filed and granted to all sorts of corporations and individuals for some of the most obvious of inventions. But there’s really nothing we can do about it, since the federal government continues to state that marijuana is not a medicine, preventing honest and not-for-profit organizations from conducting human trials. And by preventing human trials, the feds have created a large gap in research and development that can only be filled by profit-driven corporations seeking to monopolize the incredible medical properties of nature’s most unique plant.
    Once again, it seems like average citizens will fall victim to Big Pharma in their rush to claim the medical marijuana industry as their own. Sadly, it may just be a matter of time until hemp oil is wiped out and patients will be charged 10 times more for a bottle of Sativex, courtesy of the genius inventors at GW Pharmaceuticals.

    slim83 Well-Known Member

    They can't patent the compounds only the proces they use to get them

    Raeofsun13 Well-Known Member

    The government has more than one patent, they are trying to cash in, so hypocritical.

    Malevolence New Member

    Could luck patenting something any stoner can grow in his backyard for free.

    carlosvictor New Member

    Yeah the process can be patented not the product. Patenting the process will restrict others from copying or using it without the owner's permission.
    george xxx

    george xxx Active Member

    There is a lot more information out there than most people think there is. If you look at the patent applications and their listed sources for supporting documentation, it's somewhat unbelievable. How could the FDA have ever said it has no medicinal value? Some of the patent applications date back to the 70s.
    This video leads to a wealth of information

    JohnNeedsMeds Active Member

    Right, they can patent all the processes they want, it doesn't mean we will be buying that crap so let them run around like busy little beavers and process their little pills. We will continue to grow and consume our beautiful maryjane plants and laugh/smirk/chuckle at how much money they spend on those little pills that no one will want because we have the real deal. :)

    cerberus5 Member

    sadly you will indirectly pay for it through your insurance premiums or taxes depending on your countries health care services.

    AlGore Well-Known Member

    The inability to patent a natural compound has been a large hindrance to medical marijuana. Why would big phrama want a medicine to exist that they can't own? And as such marijuana laws have been as they are for the last 80(more?) years.

    So this "trend" might actually be a good thing!

Share This Page